Table 4.
Disease and survival status of patients at the time of analysis.
| Carbo-5FU | Cisplatin | pa | |
|---|---|---|---|
| n = 211 | n = 233 | ||
| Survival status | 0.03 | ||
| NED | 128 (60.7) | 155 (69.5) | |
| AWD | 4 (1.9) | 7 (3.1) | |
| DOD | 52 (24.6) | 44 (19.7) | |
| DOC | 26 (12.3) | 17 (7.6) | |
| Missing death | 1 (0.5) | 0 (0) | |
| Event | |||
| Residual disease | 13 (6.2) | 5 (2.2) | 0.041 |
| Local regional recurrence | 28 (13.3) | 30 (13.5) | 0.611 |
| Distant metastasis | 24 (11.3) | 25 (11.2) | 0.957 |
| Local regional + distant metastasis | 49 (23.2) | 47 (21.1) | 0.590 |
a
Mann–Whitney U-test was used. NED, no evidence of disease; AWD, alive with disease; DOD, died of disease; DOC, died of other cause.